CD21 Monoclonal Antibody

CD21 Monoclonal Antibody

Introducing the CD21 Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of immunology. This meticulously crafted antibody is specifically engineered to target and bind to the CD21 antigen, a crucial receptor found on the surface of B cells and follicular dendritic cells.

With its exceptional specificity and high affinity, the CD21 Monoclonal Antibody offers unparalleled accuracy in detecting and quantifying CD21 expression levels. This invaluable tool enables researchers to gain deeper insights into the intricate mechanisms of B cell activation, immune response regulation, and the pathogenesis of various diseases.

The CD21 Monoclonal Antibody boasts an innovative formulation, meticulously optimized to ensure optimal performance across a wide range of applications. Its exceptional stability and consistency guarantee reliable results, making it an indispensable asset for both basic research and clinical diagnostics.

Furthermore, this antibody is manufactured under stringent quality control measures, adhering to the highest industry standards. Rigorous testing procedures ensure batch-to-batch consistency, guaranteeing reproducibility and reliability in every experiment.

The CD21 Monoclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy integration into existing laboratory protocols. Its versatility extends to various techniques, including flow cytometry, immunohistochemistry, and Western blotting, providing researchers with the flexibility to explore diverse experimental approaches.

In summary, the CD21 Monoclonal Antibody represents a breakthrough in immunological research, offering unrivaled specificity, stability, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the understanding of CD21 biology and pave the way for groundbreaking discoveries in the field of immunology.